Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Imperatori · SciRah

Researcher profile · Semantic Scholar

M. Imperatori

Share profile

M. Imperatori — researcher profile on SciRah

h-index: 13
Works: 25
Citations: 1,187

Most-cited papers

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
M. Muscaritoli, S. Lucia, A. Farcomeni, V. Lorusso +26 more
2017OncoTarget404 citations Open access
Semantic Scholar
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D. Santini, B. Vincenzi, R. Addeo, C. Garufi +15 more
2012Annals of Oncology216 citations Open access
Semantic Scholar
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
A. Russo, M. Russano, T. Franchina, M. Migliorino +27 more
2020Advances in Therapy150 citations
Semantic Scholar
Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study.
D. Santini, B. Vincenzi, F. Guida, M. Imperatori +5 more
2012The Lancet Oncology112 citations
Semantic Scholar
Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
G. Tonini, M. Imperatori, B. Vincenzi, A. Frezza +1 more
2013Journal of experimental & clinical cancer research : CR100 citations Open access
Semantic Scholar
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients
B. Vincenzi, C. Cremolini, A. Sartore-Bianchi, A. Russo +20 more
2015OncoTarget35 citations Open access
Semantic Scholar
Premetastatic niche: ready for new therapeutic interventions?
A. Zoccoli, M. Iuliani, F. Pantano, M. Imperatori +7 more
2012Expert opinion on therapeutic targets35 citations
Semantic Scholar
New perspectives: role of Sunitinib in breast cancer.
M. E. Fratto, M. Imperatori, B. Vincenzi, F. Tomao +2 more
2011Clinica Terapeutica24 citations
Semantic Scholar
Lenvatinib for the treatment of renal cell carcinoma
G. Roviello, S. P. Corona, G. Bozza, M. Aieta +7 more
2018Expert Opinion on Investigational Drugs23 citations Open access
Semantic Scholar
Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association
L. Salvatore, M. Imperatori, E. Arnoldi, C. Carnaghi +14 more
2020ESMO Open19 citations Open access
Semantic Scholar
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience
B. Vincenzi, M. Imperatori, A. Picardi, U. Vespasiani Gentilucci +5 more
2015Expert Review of Anticancer Therapy15 citations
Semantic Scholar
Emerging kinase inhibitors of the treatment of gastric cancer
B. Vincenzi, M. Imperatori, M. Silletta, Eleonora Marrucci +2 more
2015Expert Opinion on Emerging Drugs14 citations
Semantic Scholar
Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence
G. Tonini, M. E. Fratto, M. Imperatori, F. Pantano +2 more
2011Expert Review of Anticancer Therapy14 citations
Semantic Scholar
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives
M. Imperatori, L. D'Onofrio, Eleonora Marrucci, F. Pantano +2 more
2015Hepatic Oncology13 citations Open access
Semantic Scholar
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab
F. Pantano, M. Russano, A. Berruti, G. Mansueto +34 more
2020Expert Opinion on Biological Therapy11 citations Open access
Semantic Scholar
Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?
G. Roviello, M. Imperatori, M. Aieta, F. Sollitto +1 more
2018Journal of Thoracic Disease4 citations Open access
Semantic Scholar
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D. Santini, B. Vincenzi, R. Addeo, C. Garufi +15 more
2017Annals of Oncology2 citations Open access
Semantic Scholar
A bioinformatic analysis of the aortic valve stenosis transcriptome reveals chances of Rosuvastatin treatment
T. M. Peralta, C. N. Nuñez Pedrozo, M. Porto, M. Imperatori +3 more
2021Atherosclerosis0 citations
Semantic Scholar
MON-P082: Nutritional Status in Naïve Cancer Patients Affects Long-Term Outcome. A Compelling Need for Early Intervention
S. Lucia, S. Emerenziani, M. Imperatori, M. P. Rescio +4 more
20160 citations
Semantic Scholar
L07Baseline characteristics and survival outcomes of advanced gastric cancer patients treated with two or more lines of chemotherapy: results from a large Italian cohort
L. Ferrari, C. Fontanella, M. Uccello, Giulia Pasquini +16 more
20150 citations Open access
Semantic Scholar
1539PLIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE.
M. Imperatori, B. Vincenzi, A. Picardi, U. V. Gentilucci +4 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
The Challenge of anti-EGFR therapy-rechallenge in management of metastatic colorectal cancer
D. Santini, M. Imperatori, B. Vincenzi, G. Tonini
20140 citations
Semantic Scholar
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
D. Santini, B. Vincenzi, R. Addeo, G. Masi +14 more
20120 citations
Semantic Scholar
Aprepitant is Active in the Management of Biological Therapies-Related Severe Pruritus: a Phase-II Study
D. Santini, F. Guida, G. Schiavon, O. Venditti +6 more
20120 citations Open access
Semantic Scholar
New perspectives: role of sunitinib in breast cancer.
M. E. Fratto, M. Imperatori, B. Vincenzi, F. Tomao +2 more
2010Clinica Terapeutica0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Tonini×20
Invite
G. Tonini — researcher profile on SciRah
D. Santini×16
Invite
D. Santini — researcher profile on SciRah
B. Vincenzi×15
Invite
B. Vincenzi — researcher profile on SciRah
A. Frezza×6
Invite
A. Frezza — researcher profile on SciRah

×6

Invite

O. Venditti — researcher profile on SciRah

Invite

A. Falcone — researcher profile on SciRah

Invite

F. Pantano — researcher profile on SciRah

Invite

G. Schiavon — researcher profile on SciRah

Invite

G. Aprile — researcher profile on SciRah

Invite

G. Bronte — researcher profile on SciRah

Invite

E. Maiello — researcher profile on SciRah

Invite

M. Aieta — researcher profile on SciRah